Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for stress-induced craving in OUD
NCT04051619Phase 1Completed
- Sponsor
- Brown University
- Start
- Jan 2020
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in opioid use disorder (OUD), sponsored by Brown University. Primary endpoint: Opioid Craving at Day 16. Started Jan 2020; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04051619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04051619.